Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Moatazedi
6 Jun 2024
See Remarks
Sold after exercise
175,940
$12.59
$2.21M
David Moatazedi
5 Jun 2024
See Remarks
Sold after exercise
155,278
$12.92
$2.01M

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018